Diligence memo · auto-generated · as of July 2, 2026
Quadrus Medical Technologies, Inc.
Quadrus Medical Technologies, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Quadrus Medical Technologies, Inc. operates in Biotechnology, based in WHITE PLAINS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Quadrus Medical Technologies, Inc. has raised $200K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $200K on 2018-07-01.
Most recent recorded round closed around 2018-07-01.
Valuation (modeled)modeled
Provath models Quadrus Medical Technologies, Inc. at approximately $11M (range $107K–$125M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.52× the median modeled value of Pre-Seed Biotechnology companies in 2016–2018 (152 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 8.0 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 4% of Biotechnology peers (4293 compared).
Modeled value ranks above 20% of those peers.
Closest niche peers: New Vital Signs, Inc., Cerebral Magnetics INC, NutriBand Inc., Jivana Biotechnology Inc, AnTolRx, Inc..
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.